Astria Therapeutics公布Alpha-Star 1B/2期Navenibart临床试验中所有注册Hae患者的最终积极结果
Astria Therapeutics公布Alpha-Star 1B/2期Navenibart临床试验中所有注册Hae患者的最终积极结果
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.